Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ken Griffin, Citadel Own +5% Stakes In BJ’s Restaurants & Repros Therapeutics

Ken Griffin, Citadel: This Tuesday morning in the hedge fund universe began amid some bullish moves made by Ken Griffin and his hedge fund Citadel Investment Group. In two filings with the SEC, Citadel disclosed that it currently owns almost 1.5 million shares, or 5.2% of BJ’s Restaurants, Inc. (NASDAQ:BJRI) and 1.4 million shares of Repros Therapeutics Inc (NASDAQ:RPRX), equivalent to 6.0% of the company. The value of each stake amounts to $44.9 million and $40.4 million respectively, at current market prices.


Repros Therapeutics recently announced that it conducted the second second pivotal efficacy study for Androxal, a drug that is developed for helping men with low testosterone levels caused by secondary hypogonadism. The study showed no site anomalies, the company said in a statement.

The second purchase of Citadel involved around 1.4 million shares of BJ’s Restaurants. Citadel boosted its stake in the company, after previously dumping 387,300 shares, as disclosed in the hedge fund’s most recent 13F. BJ’s Restaurants currently operates around 140 restaurants and for the second quarter of fiscal 2013, the company showed a 10% increase in revenues, which totaled around $199 million, and a net income of $8.6 million, or $0.30 per share. BJ’s Restaurants plans to open 17 new locations during its fiscal 2013, with seven in the current quarter. Check back here for more updates on Ken Griffin and Citadel.

Recommended Reading:

The Only Warren Buffett Pick Signaling ‘Buy’ Right Now

Value Investing Congress Presentations: Mick McGuire’s Bullish Thesis On United Rentals

Smithfield Foods-Starboard Value Situation Takes a New Turn

Disclosure: none

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!